Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Lower Saxony Centre for Biomedical Engineering, Implant Research and Development, Hannover, Germany.
Sci Rep. 2019 Feb 14;9(1):2091. doi: 10.1038/s41598-018-38318-4.
Fibrin glue has been used clinically for decades in a wide variety of surgical specialties and is now being investigated as a medium for local, prolonged drug delivery. Effective local delivery of antibacterial substances is important perioperatively in patients with implanted medical devices or postoperatively for deep wounds. However, prolonged local application of antibiotics is often not possible or simply inadequate. Biofilm formation and antibiotic resistance are also major obstacles to antibacterial therapy. In this paper we test the biocompatibility of bacteriophages incorporated within fibrin glue, track the release of bacteriophages from fibrin scaffolds, and measure the antibacterial activity of released bacteriophages. Fibrin glue polymerized in the presence of the PA5 bacteriophage released high titers of bacteriophages during 11 days of incubation in liquid medium. Released PA5 bacteriophages were effective in killing Pseudomonas aeruginosa PA01. Overall, our results show that fibrin glue can be used for sustained delivery of bacteriophages and this strategy holds promise for many antibacterial applications.
纤维蛋白胶在临床上已被广泛应用于多个外科专业领域,目前正被研究作为局部长期药物输送的媒介。在植入医疗器械的患者围手术期或深部伤口的患者术后,有效局部输送抗菌物质非常重要。然而,长时间局部应用抗生素往往是不可能的,或者根本不够。生物膜形成和抗生素耐药性也是抗菌治疗的主要障碍。在本文中,我们测试了纤维蛋白胶中包含的噬菌体的生物相容性,追踪了噬菌体从纤维支架中的释放,并测量了释放的噬菌体的抗菌活性。在存在 PA5 噬菌体的情况下聚合的纤维蛋白胶在液体培养基中孵育 11 天时释放出高滴度的噬菌体。释放的 PA5 噬菌体能有效杀灭铜绿假单胞菌 PA01。总的来说,我们的结果表明纤维蛋白胶可用于噬菌体的持续释放,这种策略在许多抗菌应用中具有广阔的前景。